CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Citi keeps AstraZeneca on 'buy' ahead of second-quarter results

EarningsPositive
AI Analysis

Summary

Citigroup maintains a 'buy' rating on AstraZeneca ahead of the company's second-quarter earnings results. The analyst action is routine and based on upcoming financial disclosures.

Importance:3/10
Sentiment:
0.40
earningsanalyst_ratingbuy_rating
Related Companies

Read the original article

Published by yahoo_finance on July 6, 2026 12:03 PM

Read Original